Thursday, January 29, 2009

Biota Holdings Limited: UK Government Orders 10.6 Million Courses of Relenza

Biota Holdings Limited today announced that GlaxoSmithKline has been awarded a significant contract by the UK Department of Health for 10.6 million treatment courses of RelenzaTM (zanamivir).

The details can be read here.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)